Weiler, Catherine R.

AAAAI Mast Cell Disorders Committee Work Group Report: mast cell activation syndrome (MCAS) diagnosis and management

Weiler, C. R., Austen, K. F., Akin, C., Barkoff, M. S., Bernstein, J. A., Bonadonna, P., Butterfield, J. H., Carter, M., Fox, C. C., Maitland, A., et al. (2019) · Journal of Allergy and Clinical Immunology

Mast cells and histamineFood Allergy and Anaphylaxis Research

Cited by 123

Prevention of Mast Cell Activation Disorder-Associated Clinical Sequelae of Excessive Prostaglandin D2 Production

Butterfield, J. H., & Weiler, C. R. (2008) · International Archives of Allergy and Immunology

Mast cells and histamineAsthma and respiratory diseases

Cited by 81

Mast Cell Activation Syndrome: Improved Identification by Combined Determinations of Serum Tryptase and 24-Hour Urine 11β-Prostaglandin2α

Ravi, A., Butterfield, J., & Weiler, C. R. (2014) · The Journal of Allergy and Clinical Immunology: In Practice

Mast cells and histamineAsthma and respiratory diseases

Cited by 63

The utility of measuring urinary metabolites of mast cell mediators in systemic mastocytosis and mast cell activation syndrome

Butterfield, J., & Weiler, C. R. (2020) · The Journal of Allergy and Clinical Immunology In Practice

Mast cells and histamineAsthma and respiratory diseases

Cited by 41

Omalizumab and mast cell disorders: are we there yet?

Weiler, C. R. (2019) · The Journal of Allergy and Clinical Immunology In Practice

Mast cells and histamineAsthma and respiratory diseases

Cited by 9